CA Stock MarketDetailed Quotes
OMND Optimind Pharma Corp
- 0.010
- 0.0000.00%
15min DelayMarket Closed Nov 29 13:32 ET
1.10MMarket Cap-1666P/E (TTM)
0.010High0.010Low4.00KVolume0.010Open0.010Pre Close40.00Turnover0.01552wk High0.00%Turnover Ratio109.79MShares0.00552wk Low-0.006EPS TTM931.52KFloat Cap0.200Historical HighLossP/E (Static)93.15MShs Float0.005Historical Low-0.01EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
Optimind Pharma Corp Key Stats
Quarterly+Annual
YOY
| (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | (Q3)Nov 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -50.87%-325.69K | 148.14%117.41K | 54.82%-470.27K | 98.00%-3.18K | 97.63%-7.32K | 50.48%-215.88K | -77.35%-243.89K | -1.04M | -159.06K | -308.45K |
| Net income from continuing operations | 55.01%-82.56K | 75.85%-97.5K | 54.60%-1.4M | 64.41%-706.01K | 67.02%-104.42K | 71.75%-183.5K | -214.14%-403.66K | ---3.08M | ---1.98M | ---316.61K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Depreciation and amortization | --0 | --0 | -54.39%19.95K | --0 | -54.39%4.99K | -31.58%7.48K | -31.58%7.48K | --43.74K | --10.94K | --10.94K |
| Asset impairment expenditure | ---- | ---- | -68.93%564.61K | ---- | ---- | ---- | ---- | --1.82M | ---- | ---- |
| Remuneration paid in stock | --0 | --0 | --162.4K | --0 | --0 | --0 | --162.4K | --0 | --0 | --0 |
| Deferred tax | ---- | ---- | 1.02%-8.76K | -52.22%-8.76K | ---- | ---- | ---- | ---8.85K | ---5.75K | --0 |
| Other non cashItems | ---- | ---- | -73.27%83.86K | -94.05%16.92K | -38.20%8.9K | 219.55%28.97K | 392.60%29.08K | --313.7K | --284.33K | --14.4K |
| Change In working capital | -253.23%-243.13K | 648.34%214.91K | 181.96%105.25K | 770.55%130.07K | 584.21%83.21K | 0.34%-68.83K | -72.13%-39.19K | ---128.41K | ---19.4K | ---17.18K |
| -Change in receivables | -16.85%-27.35K | 585.07%108.08K | 57.88%-43.9K | 92.20%-5.72K | 132.37%7.51K | -252.56%-23.41K | 3.66%-22.28K | ---104.24K | ---73.27K | ---23.18K |
| -Change in payables and accrued expense | -375.05%-215.78K | 731.71%106.83K | 716.95%149.15K | 152.05%135.78K | 1,161.70%75.7K | 46.19%-45.42K | -4,823.74%-16.91K | ---24.18K | --53.87K | --6K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -50.87%-325.69K | 148.14%117.41K | 54.82%-470.27K | 98.00%-3.18K | 97.63%-7.32K | 50.48%-215.88K | -77.35%-243.89K | ---1.04M | ---159.06K | ---308.45K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 89.63%-22.86K | 99.67%-212 | 55.44%-15.6K | 95.94%-3.05K | 91.21%-4K | -220.5K | -65K | -35K |
| Net business purchase and sale | --0 | --0 | --0 | -78.54%22.65K | 55.44%-15.6K | 95.94%-3.05K | 91.21%-4K | ---50K | --105.5K | ---35K |
| Net other investing changes | ---- | ---- | 86.59%-22.86K | ---- | ---- | ---- | ---- | ---170.5K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 89.63%-22.86K | 99.67%-212 | 55.44%-15.6K | 95.94%-3.05K | 91.21%-4K | ---220.5K | ---65K | ---35K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 4.41%270K | 0 | 32.53%-30.4K | 0 | -2,335.09%-277.6K | 2,368.42%258.6K | -5.00%-11.4K | -45.06K | -11.4K | -11.4K |
| Net issuance payments of debt | --0 | --0 | 32.53%-30.4K | --0 | 33.33%-7.6K | 0.00%-11.4K | 0.00%-11.4K | ---45.06K | ---10.86K | ---11.4K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2,468.42%270K | --0 | 32.53%-30.4K | --0 | 33.33%-7.6K | 0.00%-11.4K | -5.00%-11.4K | ---45.06K | ---11.4K | ---11.4K |
| Net cash flow | ||||||||||
| Beginning cash position | -50.12%146.1K | -94.80%28.7K | -70.29%552.22K | -95.93%32.08K | -94.52%62.6K | -82.41%292.93K | -70.29%552.22K | --1.86M | --787.68K | --1.14M |
| Current changes in cash | 75.82%-55.69K | 145.28%117.41K | 59.93%-523.52K | 98.56%-3.39K | 91.40%-30.52K | 55.91%-230.33K | -33.74%-259.29K | ---1.31M | ---235.46K | ---354.85K |
| End cash Position | 44.42%90.41K | -50.12%146.1K | -94.80%28.7K | -94.80%28.7K | -95.93%32.08K | -94.52%62.6K | -82.41%292.93K | --552.22K | --552.22K | --787.68K |
| Free cash from | -50.87%-325.69K | 148.14%117.41K | 54.82%-470.27K | 98.00%-3.18K | 97.63%-7.32K | 50.48%-215.88K | -77.35%-243.89K | ---1.04M | ---159.06K | ---308.45K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data